ARK Genomic Revolution ETF (BATS:ARKG) Stake Cut by McGuire Investment Group LLC

McGuire Investment Group LLC cut its stake in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 33.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,620 shares of the company’s stock after selling 5,946 shares during the quarter. McGuire Investment Group LLC’s holdings in ARK Genomic Revolution ETF were worth $274,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Wealthcare Advisory Partners LLC lifted its stake in shares of ARK Genomic Revolution ETF by 2.8% in the 4th quarter. Wealthcare Advisory Partners LLC now owns 15,903 shares of the company’s stock worth $374,000 after acquiring an additional 435 shares during the period. Crescent Grove Advisors LLC boosted its stake in ARK Genomic Revolution ETF by 1.6% in the 3rd quarter. Crescent Grove Advisors LLC now owns 28,914 shares of the company’s stock worth $740,000 after purchasing an additional 460 shares during the period. National Bank of Canada FI raised its position in ARK Genomic Revolution ETF by 28.4% during the third quarter. National Bank of Canada FI now owns 4,155 shares of the company’s stock valued at $106,000 after buying an additional 920 shares during the period. Brown Miller Wealth Management LLC lifted its position in shares of ARK Genomic Revolution ETF by 5.5% in the third quarter. Brown Miller Wealth Management LLC now owns 17,974 shares of the company’s stock worth $460,000 after purchasing an additional 933 shares in the last quarter. Finally, Dynamic Advisor Solutions LLC grew its holdings in shares of ARK Genomic Revolution ETF by 7.8% during the 3rd quarter. Dynamic Advisor Solutions LLC now owns 13,590 shares of the company’s stock valued at $348,000 after acquiring an additional 989 shares in the last quarter.

ARK Genomic Revolution ETF Price Performance

Shares of ARK Genomic Revolution ETF stock opened at $27.09 on Friday. The firm’s 50-day moving average price is $24.89 and its 200-day moving average price is $25.13.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.